Navigation Links
Better understanding of neurologic defects improves post-cardiac-arrest discharge
Date:11/14/2011

Delay in initiation of therapeutic hypothermia and delay in return of spontaneous circulation (ROSC), evidenced by a palpable pulse or a measurable blood pressure, were both associated with poor neurologic outcomes in post cardiac arrest patients, according to a study being presented Nov. 14 at the at the American Heart Association (AHA) scientific sessions in Orlando, Fla. Also, caregivers who have an appropriate understanding of the patient's post cardiac arrest neurologic state could ensure better patient management at discharge.

The researchers were seeking to determine whether there were differential rates of neurologic outcomes in post cardiac patients by time to initiation, depth and duration of therapeutic hypothermia. They based the neurologic outcomes on the Cerebral Performance Category (CPC), which is ranked from 1 to 5, with 1 identified as "good," and 3 to 5 identified as poor.

"Previous studies have collapsed several CPC scores together, namely CPC 1 and 2. CPC 1 indicates the patient is conscious, alert and able to work, with only mild neurologic and psychological deficit, while with CPC 2, the patient still has sufficient cerebral function for independent activity and able to sheltered environment," explained Susan Sendelbach, RN, of the Minneapolis Heart Institute at Abbott Northwestern Hospital in Minneapolis and researcher with Minneapolis Heart Institute Foundation.

"When you are planning discharge for patients, there is big difference between 'able to work' and 'able to work in a sheltered environment,' which really should change how we plan for discharge," she added.

Therefore, through this study, Sendelbach and her colleagues sought to further break down how the nuances of the CPC score could impact the patient and the discharge processparticularly through the separation of CPC 1 and CPC 2. Thus, they examined CPC 1, CPC 2 and CPC 3-5 independently. "We wanted to understand how the temperature management of these patients impact their neurologic outcomes," she said.

The researchers conducted a secondary data analysis from the Minneapolis Heart Institute data entered into the International Cardiac Arrest Registry (INTCAR) database in 172 adult patients who had experienced an out-of-hospital cardiac arrest undergoing therapeutic hypothermia.

The found that only two variables associated with good versus poor outcome among patients at time of ICU discharge:

  • For every five minute delay in initiating hypothermia treatment, there was a 3 percent greater odds of the patient having a poor outcome compared to a good outcome.
  • For every five minutes delay in the patient having ROSC, there is a 33 percent greater odds of the patient having a poor versus a good outcome in crude models.

"These data would support that you need to start therapeutic hypothermia as soon as possible, in addition to attempting to reach goal temperature as soon as possible in order to preserve neurologic outcomes," Sendelbach concluded.


'/>"/>

Contact: Kristin Wincek
kwincek@mhif.org
612-863-0249
Minneapolis Heart Institute Foundation
Source:Eurekalert

Related medicine news :

1. Autism-Related Hypersensitivity Better Understood
2. Developing guidelines for better reporting of health research
3. Hawaiian-shirt.net Offers 10 Tips To Beat The Winter Blues: Things You Can Do Right Now to Have a Better Day
4. Better care at any hour for palliative patients
5. Patients Do Better at Hospitals That Follow Stroke Guidelines
6. More Expensive Hospital Care May Not Mean Better
7. New MRI May Lead to Better Brain Pictures
8. Biological clock could be a key to better health, longer life
9. Why do physicians order costly CTs? Ultrasound yields better diagnosis, safer, less costly
10. BetterInvesting Magazine Releases May Stock to Study and Undervalued Stock Choices for Investors Informational and Educational Use
11. New approach to immune cell analysis seen as first step to better distinguish health and disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... 27, 2016 , ... TherapySites, the leading website ... Tennessee Counseling Association. This new relationship allows TherapySites to continue to ... adding exclusive benefits and promotional offers. , "TCA is extremely excited about this ...
(Date:6/27/2016)... ... 2016 , ... TopConsumerReviews.com recently awarded their highest five-star rating to Best Buy ... in the United States and Canada wear eyeglasses. Once considered to be a purely ... make a fashion statement. Even celebrities use glasses as a way of creating an ...
(Date:6/26/2016)... ... ... Pixel Film Studios Released ProSlice Levels, a Media Slicing Effect Plugin ... whole new perspective by using the title layers in ProSlice Levels to split-up ... Levels contains over 30 Different presets to choose from. FCPX users can ...
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... ... fertility once they have been diagnosed with endometriosis. These women need a treatment ... also require a comprehensive approach that can help for preservation of fertility and ...
(Date:6/25/2016)... , ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library on ... Observer , brings up a new, often overlooked aspect of head lice: the parasite’s ability ... fumigation is not a common occurrence, but a necessary one in the event that lice ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... One of Australia,s successful biotechnology scientists, Dr ... biotechnology company, Noxopharm Limited [ABN 50 608 966 123] ("Noxopharm"). Noxopharm ... on the ASX. Noxopharm is a clinic-ready company with ... 1 clinical study later this year. ... problems facing cancer patients - the ability of cancers to become ...
(Date:6/26/2016)... , June 27, 2016 Jazz Pharmaceuticals ... waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of ... acquisition of Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: ... p.m. (Eastern Daylight Time). As previously announced ... into a definitive merger agreement under which Jazz Pharmaceuticals ...
(Date:6/26/2016)... OTTAWA, Ontario , June 27, 2016  VMS ... the Company,s Board will take whatever measures required to ... the Company,s stock which is currently listed on the ... S Wexler, Company Chairman and CEO, "We are seeing ... be difficult to understand, not only by the Company, ...
Breaking Medicine Technology: